Replies to post #284807 on Anavex Life Sciences Corp (AVXL)

[dadbrotheroftwins]

I believe it will go down, as the results will not meet primary endpoints apparently, because if it did it would have been announced at CTAD. There will be a lot of meaningful benefits, that will lead to phase 3 justification, but I think just from the results of the trial sp will drop. It may go back up slowly, in anticipation of Rett readout, but that isn't a given.